Back to Search
Start Over
Gastrointestinal dysfunction and enteric neurotoxicity following treatment with anticancer chemotherapeutic agent 5-fluorouracil
- Source :
- Digital.CSIC. Repositorio Institucional del CSIC, instname
- Publication Year :
- 2016
-
Abstract
- [Background]: The use of the anticancer chemotherapeutic agent 5-fluorouracil (5-FU) is often limited by nausea, vomiting, constipation, and diarrhea; these side-effects persist long after treatment. The effects of 5-FU on enteric neurons have not been studied and may provide insight into the mechanisms underlying 5-FU-induced gastrointestinal dysfunction. [Methods]: Balb/c mice received intraperitoneal injections of 5-FU (23 mg/kg) 3 times/week for 14 days. Gastrointestinal transit was analysed in vivo prior to and following 3, 7, and 14 days of 5-FU treatment via serial x-ray imaging. Following 14 days of 5-FU administration, colons were collected for assessment of ex vivo colonic motility, gross morphological structure, and immunohistochemical analysis of myenteric neurons. Fecal lipocalin-2 and CD45 leukocytes in the colon were analysed as markers of intestinal inflammation. [Key Results]: Short-term administration of 5-FU (3 days) increased gastrointestinal transit, induced acute intestinal inflammation and reduced the proportion of neuronal nitric oxide synthase-immunoreactive neurons. Long-term treatment (7, 14 days) resulted in delayed gastrointestinal transit, inhibition of colonic migrating motor complexes, increased short and fragmented contractions, myenteric neuronal loss and a reduction in the number of ChAT-immunoreactive neurons after the inflammation was resolved. Gross morphological damage to the colon was observed following both short- and long-term 5-FU treatment. [Conclusions & Inferences]: Our results indicate that 5-FU induces accelerated gastrointestinal transit associated with acute intestinal inflammation at day 3 after the start of treatment, which may have led to persistent changes in the ENS observed after days 7 and 14 of treatment contributing to delayed gastrointestinal transit and colonic dysmotility.<br />This work was supported by a research grant from Victoria University.
- Subjects :
- Male
medicine.medical_specialty
Physiology
Colon
Gastrointestinal Diseases
medicine.medical_treatment
Inflammation
Antineoplastic Agents
Gastroenterology
Enteric Nervous System
03 medical and health sciences
Mice
0302 clinical medicine
Organ Culture Techniques
Internal medicine
medicine
Animals
5-fluorouracil
5-FU
Gastrointestinal Transit
Migrating motor complex
Gastrointestinal tract
Chemotherapy
Mice, Inbred BALB C
Endocrine and Autonomic Systems
Enteric neuropathy
business.industry
Neurotoxicity
medicine.disease
Myenteric neurons
030220 oncology & carcinogenesis
Gastrointestinal transit
Colonic motility
030211 gastroenterology & hepatology
Enteric nervous system
Fluorouracil
medicine.symptom
business
Ex vivo
Subjects
Details
- ISSN :
- 13652982
- Volume :
- 28
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society
- Accession number :
- edsair.doi.dedup.....657276df7a76d99e4654b498dd7c93ca